对 "重组猪序列因子 VIII 在治疗获得性 A 型血友病中的实际应用：欧盟 PASS "的更正。

IF 3.4 3区医学 Q2 HEMATOLOGY

Therapeutic Advances in Hematology Pub Date : 2024-10-04 eCollection Date: 2024-01-01 DOI:10.1177/20406207241288442

引用次数: 0

摘要

[此处更正了文章 DOI：10.1177/20406207241260332]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to "Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS".

[This corrects the article DOI: 10.1177/20406207241260332.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic Advances in Hematology HEMATOLOGY-

CiteScore

4.30

自引率

0.00%

发文量

审稿时长

7 weeks

期刊介绍： Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.